Ribolia
Kunshan, CN · 2 known investors
Find your way into Ribolia
Sign up to see every warm intro you have to Ribolia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ribolia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ribolia (瑞博生物) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
Founders & leadership
梁
梁子才Founding Chairman & Chief Executive Officer
张
张鸿雁Founding President
甘
甘黎明Co-Chief Executive Officer & Global President of R&D
Investors · 2
Frequently asked questions
- What does Ribolia do?
- Ribolia (瑞博生物) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
- Who founded Ribolia?
- Ribolia was founded by 梁子才, 张鸿雁.
- Who are Ribolia's investors?
- Ribolia's investors include Blue Ocean Capital Group, Pan-Lin Capital.
- Where is Ribolia headquartered?
- Ribolia is headquartered in Kunshan, CN.